Strong data, health stocks lead Wall St higher


Traders work on the floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., December 29, 2016. REUTERS/Andrew Kelly

NEW YORK: Strong economic data and gains in healthcare stocks propped up Wall Street on Thursday, a day after the S&P 500 suffered its biggest fall in two months.

A report showed the number of Americans applying for jobless claims fell by 10,000 to 265,000 last week, indicating sustained strength in the labour market.

US equities had been enjoying a rally since the presidential election in November on bets that Donald Trump would introduce tax cuts, deregulation and higher infrastructure spending that would spur economic growth.

The near two-month rally has seen the three main Wall Street indexes rack up double-digit percentage gains, but has left some market participants nervous about a potential correction.

The S&P 500 index suffered its biggest one-day percentage drop on Wednesday, following weak housing data and losses in the technology sector. The triple-digit loss on the Dow pulled it further away from its march towards 20,000.

At 9:38am ET the Dow Jones industrial average was up 34.26 points, or 0.17%, at 19,867.94 The S&P 500 was up 3.98 points, or 0.17%, at 2,253.9.

The Nasdaq Composite was up 10.93 points, or 0.2%, at 5,449.49.

Nine of the 11 major S&P 500 sectors were higher, led by gains in industrials and utilities.

Nvidia’s shares fell 2.5% to US$106.31, a day after short-seller Citron Research tweeted that the chipmaker’s stock could fall to US$90 in 2017.

Shares of Advanced Micro Devices, Nvidia’s rival, were off 0.7%.

Cempra dropped 50% to US$2.98 after the drug developer said the US Food and Drug Administration rejected its antibiotic treatment for pneumonia.

Advancing issues outnumbered decliners on the NYSE by 1,920 to 635. On the Nasdaq, 1,582 issues rose and 624 fell.

The S&P 500 index showed 1 new 52-week highs and two new lows, while the Nasdaq recorded 28 new highs and 11 new lows. - Reuters


Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih
FBM KLCI rebounds to hit fresh two-year high
Asian FX subdued after mixed US data; equities set for weekly gains
Global manufacturing activity recovery to continue gradually into 2024 - S&P Global
Country Garden plans to present debt revamp plan in second half, sources say

Others Also Read